Hyponatremia
3 competing products in clinical development for Hyponatremia.
Pipeline by Phase
Phase 32
Approved1
All Products (3)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| YM087 | Astellas Pharma | Phase 3 | Completed | 40 |
| Conivaptan | Astellas Pharma | Approved | Terminated | 35 |
| Conivaptan | Astellas Pharma | Phase 3 | Withdrawn | 32 |